The rational design of specific peptide inhibitor against p38α MAPK at allosteric-site: a therapeutic modality for HNSCC.

Gill K, Nigam L, Singh R, Kumar S, Subbarao N, Chauhan SS, Dey S

Open source

DOI
10.1371/journal.pone.0101525
Published
2014
Container
PloS one
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1371/journal.pone.0101525,
  title = {The rational design of specific peptide inhibitor against p38α MAPK at allosteric-site: a therapeutic modality for HNSCC.},
  author = {Gill K and Nigam L and Singh R and Kumar S and Subbarao N and Chauhan SS and Dey S},
  year = {2014},
  journal = {PloS one},
  doi = {10.1371/journal.pone.0101525},
  url = {https://doi.org/10.1371/journal.pone.0101525}
}

RIS

TY  - JOUR
TI  - The rational design of specific peptide inhibitor against p38α MAPK at allosteric-site: a therapeutic modality for HNSCC.
AU  - Gill K
AU  - Nigam L
AU  - Singh R
AU  - Kumar S
AU  - Subbarao N
AU  - Chauhan SS
AU  - Dey S
PY  - 2014
JO  - PloS one
DO  - 10.1371/journal.pone.0101525
UR  - https://doi.org/10.1371/journal.pone.0101525
ER  - 

APA

K, G., L, N., R, S., S, K., N, S., SS, C., & S, D. (2014). The rational design of specific peptide inhibitor against p38α MAPK at allosteric-site: a therapeutic modality for HNSCC.. PloS one. https://doi.org/10.1371/journal.pone.0101525

Source records